|
|
|
Friday, April 18, 2014
|
|
|
|
|
|
 Did Chimerix, Inc. Set A Bad Example For Biopharma?
Chimerix generated some pretty negative publicity when it denied a dying seven-year old boy access to its experimental drug brincidofovir. Josh Hardy had developed an adenovirus infection following a bone marrow transplant related to past cancer treatment. Since Chimerix has a drug that has demonstrated some efficacy (albeit much of it anecdotal) in exactly this indication, doctors recommended the parents see about getting the medicine on a "compassionate use" basis. The company, however, demurred. More...
|
|
|
|
|
|
|
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.
Show me jobs for this employer
|
|
|
|
|
|
|
|
Emerging Job Search Trends In 2014
More...
|
Hiring Managers Reveal The 15 BEST Words To Use On Your Resume
More...
|
10 Interview Questions; The Good, Bad, And The Ugly
More...
|
What Your Body Language Is Saying During The Interview
More...
|
The 2 Stages Of Job Search Rejection
More...
|
5 Resume Errors That Will Land You In The Trash
More...
|
5 Rules Of Employment Follow-Up
More...
|
3 Executive Resume Bloopers You’re Making Right Now
More...
|
3 Secrets To Interview-Winning Cover Letters
More...
|
6 Ways To Handle Irritating Colleagues
More...
|
|
|
|
|
|
|
|
|
|
|
|
|